================================================================================
                    STANDARD OPERATING PROCEDURES
                    BIOPHARMA INDUSTRIES LIMITED
================================================================================

This document contains example SOPs representing the 287 SOPs maintained by
BioPharma Industries Limited for GMP compliance.

================================================================================

SOP 1: CLEANING OF TABLET COMPRESSION MACHINE
============================================

--------------------------------------------------------------------------------
SOP NUMBER:           SOP/MFG/045
VERSION:              3.0
EFFECTIVE DATE:       January 1, 2024
REVIEW DATE:          December 31, 2025
PAGE:                 1 of 5
--------------------------------------------------------------------------------

1. PURPOSE

To describe the procedure for cleaning of tablet compression machine after
each batch to prevent cross-contamination and ensure GMP compliance.

2. SCOPE

This SOP applies to all tablet compression machines in the manufacturing area
including Cadmach CMD4-45 (TAB-001, TAB-002) and Fette P3000 (TAB-003).

3. RESPONSIBILITY

- Production Operator: Performs cleaning
- Production Supervisor: Verifies cleaning
- QA Inspector: Approves cleaned equipment

4. DEFINITIONS

- Product Contact Parts: Parts that come in direct contact with the product
- Major Cleaning: Complete dismantling and cleaning (product changeover)
- Minor Cleaning: Cleaning without full dismantling (same product, batch change)

5. MATERIALS REQUIRED

- Potable water
- Purified water
- Detergent (approved cleaning agent - Teepol)
- 70% Isopropyl Alcohol (IPA)
- Lint-free wipes
- Cleaning brushes
- Vacuum cleaner (dedicated)

6. PERSONAL PROTECTIVE EQUIPMENT

- Gloves (nitrile)
- Face mask
- Safety goggles
- Hair cover
- Gown

7. PROCEDURE

7.1 PREPARATION

7.1.1 Stop the machine and switch off the main power supply.
7.1.2 Display "UNDER CLEANING" status label.
7.1.3 Remove all tablets from hopper, feeder, and die cavities.
7.1.4 Collect tablets in labeled container and send for reconciliation.

7.2 DISMANTLING

7.2.1 Remove upper punches and place in designated tray.
7.2.2 Remove lower punches and place in designated tray.
7.2.3 Remove dies using die removal tool.
7.2.4 Remove feed frame and hopper.
7.2.5 Remove turret guards and safety covers.

7.3 CLEANING OF DISMANTLED PARTS

7.3.1 Vacuum any remaining powder from parts.
7.3.2 Rinse parts with potable water to remove bulk residue.
7.3.3 Prepare cleaning solution (2% Teepol in potable water).
7.3.4 Scrub all parts with cleaning solution using nylon brushes.
7.3.5 Pay special attention to punch tips, die bores, and feed frame channels.
7.3.6 Rinse thoroughly with potable water until no soap residue remains.
7.3.7 Final rinse with purified water.
7.3.8 Wipe with 70% IPA.
7.3.9 Air dry or dry with lint-free cloth.

7.4 CLEANING OF MACHINE BODY

7.4.1 Vacuum all surfaces to remove loose powder.
7.4.2 Wipe turret surface with damp cloth (purified water).
7.4.3 Clean punch guides and cam tracks with IPA.
7.4.4 Wipe all external surfaces with 70% IPA.
7.4.5 Clean compression rollers and adjustment mechanisms.

7.5 REASSEMBLY

7.5.1 Reassemble all cleaned parts in reverse order.
7.5.2 Ensure proper seating of dies and alignment of punches.
7.5.3 Lubricate moving parts as per machine manual.

7.6 DOCUMENTATION

7.6.1 Record cleaning details in Equipment Cleaning Log.
7.6.2 Affix "CLEANED" label with date, time, product cleaned from, and signature.

8. CLEANING VALIDATION

This cleaning procedure has been validated (CV/TAB001/2023/001).
Acceptance criteria:
- Visual: No visible residue
- Swab test: Previous product residue <10 ppm
- Rinse test: Detergent residue <10 ppm

9. HOLD TIME

Maximum hold time after cleaning: 7 days
If exceeded, re-clean before use.

10. REFERENCES

- SOP/QA/025 - Cleaning Validation
- Equipment Manual - Cadmach CMD4

--------------------------------------------------------------------------------
Prepared by: Mr. Suresh Sharma, Production Manager
Reviewed by: Mrs. Deepika Jain, Head QA
Approved by: Dr. Rajendra Patil, Technical Director
--------------------------------------------------------------------------------

================================================================================

SOP 2: OUT-OF-SPECIFICATION (OOS) INVESTIGATION
==============================================

--------------------------------------------------------------------------------
SOP NUMBER:           SOP/QC/045
VERSION:              4.0
EFFECTIVE DATE:       April 1, 2024
REVIEW DATE:          March 31, 2026
PAGE:                 1 of 8
--------------------------------------------------------------------------------

1. PURPOSE

To establish a systematic procedure for investigation of Out-of-Specification
(OOS) results to determine the root cause and implement corrective actions.

2. SCOPE

This SOP applies to all OOS results obtained during testing of raw materials,
in-process samples, finished products, and stability samples in the QC laboratory.

3. RESPONSIBILITY

- Analyst: Reports OOS, participates in investigation
- QC Supervisor: Initiates Phase I investigation
- QC Head: Reviews Phase I, initiates Phase II
- QA Head: Final review and approval
- Production Manager: Phase II manufacturing investigation

4. DEFINITIONS

Out-of-Specification (OOS): Test result that falls outside established
acceptance criteria or specifications.

Out-of-Trend (OOT): Test result that is within specification but shows an
unexpected trend compared to historical data.

Assignable Cause: An identifiable cause for the OOS result.

5. PROCEDURE

5.1 IDENTIFICATION AND REPORTING

5.1.1 When an OOS result is obtained, the analyst shall:
      a) Stop testing immediately
      b) Retain all solutions, samples, and documentation
      c) Inform the QC Supervisor within 1 hour
      d) Document in OOS Log (Form QC/045/F01)

5.1.2 QC Supervisor shall assign OOS number: OOS-YYYY-NNN

5.2 PHASE I: LABORATORY INVESTIGATION (Within 3 working days)

5.2.1 QC Supervisor shall initiate Phase I investigation immediately.

5.2.2 Review the following:

      a) ANALYST PERFORMANCE
         - Training records
         - Recent performance on similar tests
         - Calculation errors

      b) SAMPLE HANDLING
         - Sample integrity
         - Proper labeling
         - Storage conditions
         - Preparation procedure

      c) INSTRUMENT/EQUIPMENT
         - Calibration status
         - Maintenance records
         - System suitability (for HPLC/GC)
         - Performance logs

      d) REFERENCE STANDARDS AND REAGENTS
         - Expiry dates
         - Storage conditions
         - Preparation records

      e) TEST METHOD
         - Correct procedure followed
         - Correct specification applied
         - Calculations verified

      f) DATA INTEGRITY
         - Raw data reviewed
         - Chromatograms reviewed
         - No transcription errors

5.2.3 Document findings in Phase I Investigation Report (Form QC/045/F02).

5.3 PHASE I OUTCOMES

5.3.1 If assignable laboratory cause is found:
      a) Document the cause
      b) Invalidate the original result with justification
      c) Implement corrective action
      d) Retest using same sample
      e) Report retest result

5.3.2 If no assignable laboratory cause is found:
      a) Confirm original result with second analyst
      b) If confirmed, proceed to Phase II

5.4 PHASE II: MANUFACTURING INVESTIGATION (Within 10 working days)

5.4.1 QC Head shall notify Production and QA to initiate Phase II.

5.4.2 Manufacturing investigation shall cover:

      a) BATCH RECORD REVIEW
         - All manufacturing steps followed
         - No deviations
         - IPC results

      b) ENVIRONMENTAL CONDITIONS
         - Temperature, humidity records
         - Any excursions

      c) EQUIPMENT
         - Qualification status
         - Cleaning records
         - Any equipment issues

      d) RAW MATERIALS
         - Supplier COAs
         - Testing results
         - Any quality issues

      e) PROCESS PARAMETERS
         - All parameters within range
         - No process changes

      f) PERSONNEL
         - Training status
         - Any human errors

5.4.3 Document findings in Phase II Investigation Report (Form QC/045/F03).

5.5 ADDITIONAL TESTING

5.5.1 Additional testing may include:
      - Retesting of original sample
      - Testing of additional sample units
      - Testing of retain sample (same batch)
      - Testing of additional batches

5.5.2 Averaging of results is NOT permitted except when specified in the
      test method (e.g., content uniformity).

5.6 CONCLUSION AND DECISION

5.6.1 Based on investigation findings:

      a) ASSIGNABLE CAUSE FOUND (Lab or Manufacturing):
         - Implement CAPA
         - Invalidate affected result if appropriate
         - Accept retest result
         - Document justification

      b) NO ASSIGNABLE CAUSE FOUND:
         - Original OOS result stands
         - Batch must be rejected or reprocessed
         - Evaluate impact on other batches

5.6.2 Document final conclusion in OOS Summary Report (Form QC/045/F04).

5.7 CAPA

5.7.1 For all confirmed OOS results:
      a) Identify root cause
      b) Implement corrective action
      c) Implement preventive action
      d) Verify effectiveness

5.7.2 CAPA shall be tracked to closure.

5.8 TIMELINE

Activity                              Timeline
------------------------------------------------
OOS identification to Phase I start   Immediate
Phase I completion                    3 working days
Phase II initiation (if needed)       1 working day
Phase II completion                   10 working days
CAPA implementation                   As per CAPA plan

5.9 TRENDING

5.9.1 OOS data shall be trended monthly and reviewed in Management Review.
5.9.2 Trends by product, test, analyst, and equipment shall be analyzed.

6. RECORDS

- OOS Log
- Phase I Investigation Report
- Phase II Investigation Report
- OOS Summary Report
- CAPA records

7. REFERENCES

- FDA Guidance for Industry: Investigating OOS Test Results
- ICH Q10 Pharmaceutical Quality System

--------------------------------------------------------------------------------
Prepared by: Dr. Anita Shah, Head QC
Reviewed by: Mrs. Deepika Jain, Head QA
Approved by: Dr. Rajendra Patil, Technical Director
--------------------------------------------------------------------------------

================================================================================

SOP 3: ENVIRONMENTAL MONITORING
==============================

--------------------------------------------------------------------------------
SOP NUMBER:           SOP/QA/032
VERSION:              3.0
EFFECTIVE DATE:       July 1, 2024
PAGE:                 1 of 6
--------------------------------------------------------------------------------

1. PURPOSE

To establish a procedure for environmental monitoring of manufacturing and
testing areas to ensure GMP compliance and product quality.

2. SCOPE

This SOP covers viable and non-viable particle monitoring in Grade D
manufacturing areas and QC laboratory.

3. MONITORING PARAMETERS

3.1 NON-VIABLE PARTICLES

Particle Counter:     Met One 3400
Locations:            Production areas, QC lab
Frequency:            Daily during operations

Limits (Grade D - At Rest):
- ≥0.5 µm: NMT 3,520,000 particles/m³
- ≥5.0 µm: NMT 29,000 particles/m³

3.2 VIABLE MONITORING

Methods:
- Settle plates (90mm TSA, 4-hour exposure)
- Active air sampling (SAS sampler, 1000L)
- Surface monitoring (contact plates/swabs)

Locations:           Per sampling plan
Frequency:           Weekly (more during production)

Limits (Grade D):
- Settle plates: NMT 100 CFU/4 hours
- Air samples: NMT 200 CFU/m³
- Contact plates: NMT 50 CFU/55mm plate

4. ALERT AND ACTION LIMITS

Level         Particle Count    Settle Plate    Air Sample
------------------------------------------------------------
Normal        Within limit      ≤50 CFU         ≤100 CFU
Alert         80% of limit      51-75 CFU       101-150 CFU
Action        At limit          76-100 CFU      151-200 CFU
OOS           Exceeds limit     >100 CFU        >200 CFU

5. PROCEDURE

5.1 NON-VIABLE MONITORING

5.1.1 Calibrate particle counter before use.
5.1.2 Sample at 1 cubic foot at each location.
5.1.3 Record results in Environmental Monitoring Log.
5.1.4 Investigate any exceedances.

5.2 VIABLE MONITORING

5.2.1 Collect settle plates, air samples, and contact plates per schedule.
5.2.2 Incubate plates at 30-35°C for 48-72 hours (bacteria) and
      20-25°C for 5-7 days (fungi).
5.2.3 Count colonies and record results.
5.2.4 Investigate any exceedances.

6. INVESTIGATION AND CAPA

6.1 Alert Level: Investigate, trend, increase monitoring frequency.
6.2 Action Level: Investigate, initiate CAPA, inform production.
6.3 OOS: Stop production, deep clean, investigate, re-sample.

7. TRENDING

Monthly trend analysis of all environmental monitoring data.
Annual summary in Product Quality Review.

--------------------------------------------------------------------------------

================================================================================

SOP 4: CHANGE CONTROL
====================

--------------------------------------------------------------------------------
SOP NUMBER:           SOP/QA/015
VERSION:              5.0
EFFECTIVE DATE:       January 1, 2025
PAGE:                 1 of 7
--------------------------------------------------------------------------------

1. PURPOSE

To establish a system for proposing, evaluating, approving, implementing,
and documenting changes that may affect product quality.

2. SCOPE

All changes to processes, equipment, materials, facilities, documents, and
systems that may impact product quality or regulatory compliance.

3. CHANGE CLASSIFICATION

CRITICAL: Changes requiring regulatory approval before implementation
- Change in manufacturing site
- Change in formulation
- Change in active ingredient supplier

MAJOR: Changes requiring QA approval and may need stability data
- Change in equipment (same principle)
- Change in process parameters beyond validated range
- Change in packaging material

MINOR: Changes requiring QA approval
- Editorial changes to documents
- Like-for-like equipment replacement
- Administrative changes

4. PROCEDURE

4.1 INITIATION

4.1.1 Requester completes Change Control Form (QA/015/F01).
4.1.2 Describes current state, proposed change, and justification.
4.1.3 Submits to QA for registration.

4.2 EVALUATION

4.2.1 QA registers change and assigns number: CC-YYYY-NNN.
4.2.2 Impact assessment team evaluates:
      - Regulatory impact
      - Quality impact
      - Validation impact
      - Stability impact
      - Documentation impact

4.3 APPROVAL

4.3.1 Approval based on classification:
      - Critical: MD/Technical Director + Regulatory filing
      - Major: QA Head + affected department heads
      - Minor: QA Manager

4.4 IMPLEMENTATION

4.4.1 Implement change per approved plan.
4.4.2 Update all affected documents.
4.4.3 Train affected personnel.
4.4.4 Complete validation/qualification if required.

4.5 CLOSURE

4.5.1 Verify all actions completed.
4.5.2 Review effectiveness.
4.5.3 Close change control.

5. TIMELINE

- Registration: Within 2 days of receipt
- Evaluation: Within 5 days
- Implementation: As per approved timeline
- Closure: Within 30 days of implementation

6. EMERGENCY CHANGES

For urgent changes affecting production:
- Verbal approval from QA Head
- Documentation within 24 hours
- Full evaluation within 5 days

--------------------------------------------------------------------------------

================================================================================

SOP INDEX (Total 287 SOPs)
=========================

QUALITY ASSURANCE (QA/001-050)
- QA/001: Document Control
- QA/005: Training and Qualification
- QA/010: Internal Audits
- QA/015: Change Control
- QA/020: Deviation and CAPA
- QA/025: Cleaning Validation
- QA/030: Product Quality Review
- QA/032: Environmental Monitoring
- QA/035: Supplier Qualification
- QA/040: Batch Release
- QA/045: Complaint Handling
- QA/050: Product Recall

QUALITY CONTROL (QC/001-080)
- QC/001: Sample Management
- QC/010: Analytical Method Validation
- QC/020: HPLC Operation
- QC/025: Dissolution Testing
- QC/030: Microbial Testing
- QC/035: Stability Studies
- QC/040: Reference Standards
- QC/045: OOS Investigation
- QC/050: Calibration

PRODUCTION (PRD/001-100)
- PRD/005: Area Clearance
- PRD/010: Dispensing
- PRD/015: Blending
- PRD/020: Granulation
- PRD/025: Drying
- PRD/030: Compression
- PRD/035: Coating
- PRD/040: Capsule Filling
- PRD/045: Equipment Cleaning

PACKAGING (PKG/001-030)
- PKG/005: Primary Packing
- PKG/010: Secondary Packing
- PKG/015: Coding and Labeling

WAREHOUSE (WH/001-030)
- WH/001: Material Receipt
- WH/010: Storage
- WH/015: Dispatch

ENGINEERING (ENG/001-040)
- ENG/001: Preventive Maintenance
- ENG/010: Calibration
- ENG/020: HVAC Operation
- ENG/030: Water System

================================================================================
                    END OF STANDARD OPERATING PROCEDURES
================================================================================
